Sale

Chronic Lower Back Pain Treatment Market

Global Chronic Lower Back Pain Treatment Market Share, Size: By Pain Type: Discogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet- Joint Pain, Radicular Pain, Muscular Pain, Others; By Diagnosis: Clinical History, Physical Examination, Others; By Treatment Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Chronic Lower Back Pain Treatment Market Outlook

The global chronic lower back pain treatment market size was estimated to be worth USD 8.29 billion in 2023. The market is expected to rise at a CAGR of 4.9% in the forecast period of 2024-2032, and by 2032, the market value is anticipated to be worth USD 12.75 billion. The rise in the neurological disorders and the sedentary lifestyle of the people are the primary market drivers.

 

chronic-lower-back-pain-treatment-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Chronic Lower Back Pain: Insights, Aetiology , Diagnosis, and Treatment

Chronic lower back pain is a type of back pain which lasts for a period of twelve weeks and more. This pain continues to persist even after the treatment of acute lower back pain.

 

Numerous factors account for the aetiology of chronic lower back pain. The main causes of chronic lower back pain are congenital disorders, injuries, degenerative problems, nerve and spinal cord problems. These all causes are mechanical in nature.

 

The congenital causes include skeletal disorders and spina bifida. Sprains or any type of traumatic injury are also responsible for chronic lower back pain. The non-spinal causes of chronic lower back pain include kidney stones, endometriosis, tumours, fibromyalgia, and pregnancy.

 

The risk factors of chronic lower back pain include increasing age, smoking, and genetic and psychological factors. Improper lifestyle patterns and improper postures significantly increase the chances of chronic lower back pain.

 

The diagnosis and management of chronic lower back pain account for the chronic lower back pain treatment market. The diagnostic tests include blood tests, bone scans, and discography. Diagnostic imaging tests, such as computerised tomography, magnetic resonance imaging, and X-ray imaging are also used to assess the body’s anatomy.

 

Chronic lower back pain is treated through a proper step-by-step procedure. The treatment begins with the essential medications with more effective and advanced approaches.

 

According to the chronic lower back pain treatment market research report, the market can be categorised into the following segments:

 

chronic-lower-back-pain-treatment-market-by-segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Pain Type

  • Discogenic Pain
  • Lumbar Spinal Stenosis
  • Sacroiliac Pain
  • Facet- Joint Pain
  • Radicular Pain
  • Muscular Pain
  • Others

 

Market Breakup by Diagnosis

  • Clinical History
  • Physical Examination
  • Imaging Guidelines
  • Others

 

Market Breakup by Treatment Channel

  • Public
  • Private

 

Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

chronic-lower-back-pain-treatment-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Chronic Lower Back Pain Treatment Market Scenario

The increasing prevalence of neurological disorders drives the growth of the chronic lower back pain treatment market. The neurological system consists of the brain and spinal cord, so it directly affects the lower back and cause sensations that stimulate lower back pain. Inactive lifestyle patterns are also contributing to lower back pain.

 

The increased adoption of painkillers for all pain types also stimulate the market growth to a significant extent. The increased sales of painkillers will facilitate the generation of more significant revenues, aiding the expansion of the market.

 

Additional factors aiding the growth of the market include the rising incidence of lower back pain cases, increasing healthcare expenditure, and better awareness. According to the National Institute of Neurological disorders and stroke, around 80% of adults experience acute or chronic lower back pain discomfort once in a lifetime.

 

Regional Outlook

North America Accounts for the Largest Market Share

North American regional market is dominating the chronic lower back pain treatment market owing to the advanced healthcare infrastructure, rising prevalence, and increasing research and development activities.

 

Asia Pacific is Among the Fastest Growing Region

The Asia Pacific region is anticipated to be the fastest growing region due to increasing developmental activities and the rising geriatric population.

 

Therapeutic Landscape

Chronic lower back pain is the most prevalent chronic pain disorder. The neuropathic component is responsible for the chronic pain and the rising prevalence of other comorbidities. 

 

The exact cause or mechanism of chronic lower back pain is not known. Due to this, there are no universally accepted therapeutic interventions. The main aim of the treatment is to alleviate the symptoms and reduce the intensity of pain. For the management of pain, several options are available in the chronic lower back pain treatment market.

 

Potent Treatment Options: Medications, Physical Therapy Programs, and Surgical Procedures

Chronic lower back pain treatment initiates with anti-inflammatory medications. The physician may also prescribe anticonvulsants, antidepressants, and opioid drugs to manage chronic pain. Along with this, self-management techniques like hot or cold packs and physical exercises can also be incorporated into the treatment schedule for more effective results.

 

Complementary and alternative management techniques like acupuncture, transcutaneous electrical nerve stimulation, spinal mobilisation and physical therapy programs are used to restore mobility and reduce pain sensations. Spinal injections carrying suitable medications can also be given for immediate pain relief.

 

Surgical procedures are considered for specific indications when the above treatment methods fail. The different surgeries for management of chronic lower back pain are vertebroplasty, spinal laminectomy, discectomy, foraminotomy and nucleoplasty.

 

Over the last decade, developments in back pain therapies have accelerated and resulted in multiple effective treatment options. These novel therapies and strategies have grabbed the attention of the key players. This will assist in the growth of the chronic lower back pain treatment market.

 

Clinical Trial Landscape

Technological advancements and extensive clinical research contribute to discovering more innovative therapeutic methods. The trials for the novel medications are under process and, once completed, will lead to the development of novel targeted therapies.

 

Emerging Therapeutic Options Under Pipeline

A randomised clinical trial was performed by the scientists of the United States, Europe, and Australia to assess the efficacy of their novel method called RESOLVE. This new program is called the graded sensorimotor retraining intervention. In this program, brain-back communication is improved by retraining the brain. The results suggested that this helps decrease the pain intensity of the lower back.

 

Eli Lilly and Company, one of the leading key players, is also performing Phase II clinical trials for its novel medication that effectively manages chronic back pain. This drug acts by blocking the potent cation channels, thus suppressing the pain sensations.

 

The incorporation of advanced technologies has also stimulated the development of effective treatments. Abbott, a key player, has successfully performed clinical trials for its new Proclaim Plus spinal cord stimulation system. This system will mimic the natural patterns found in the brain and will assist in pain management.

 

Several ongoing clinical trials are emerging as a driving factor for chronic lower back pain treatment market growth and development.

 

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

 

  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Medtronic plc
  • Endo International plc
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Karl Storz SE & Co. KG
  • Stryker Corporation

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Pain Type
  • Diagnosis
  • Treatment Channel
  • Region
Breakup by Pain Type
  • Discogenic Pain
  • Lumbar Spinal Stenosis
  • Sacroiliac Pain
  • Facet- Joint Pain
  • Radicular Pain
  • Muscular Pain
  • Others
Breakup by Diagnosis
  • Clinical History
  • Physical Examination
  • Imaging Guidelines
  • Others
Breakup by Treatment Channel
  • Public
  • Private
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Medtronic plc
  • Endo International plc
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Karl Storz SE & Co. KG
  • Stryker Corporation

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
2    Research Methodology
3    Executive Summary
4    Chronic Lower Back Pain Overview

    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Treatment Pathway 
5    Patient Profile
    5.1    Patient Profile Overview
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Treatment Success Rate
6    Current Scenario Evaluation and Regulatory Framework
    6.1    Emerging Therapies and Clinical Trials
    6.2    Patent Landscape 
        6.2.1    Patent Overview
            6.2.1.1    Patent Status and Expiry
            6.2.1.2    Timelines from Drug Development to Commercial Launch
            6.2.1.3    New Drug Application
                6.2.1.3.1    Documentation and Approval Process
    6.3    Cost of Treatment
    6.4    Regulatory Framework
        6.4.1    Regulatory Overview
            6.4.1.1    US FDA
            6.4.1.2    EU EMA
            6.4.1.3    INDIA CDSCO
            6.4.1.4    JAPAN PMDA
            6.4.1.5    Others
7    Challenges and Unmet Needs
    7.1    Treatment Pathway Challenges
    7.2    Compliance and Drop-Out Analysis
    7.3    Awareness and Prevention Gaps
8    Global Chronic Lower Back Pain Treatment Market
    8.1    Global Chronic Lower Back Pain Treatment Market Overview
    8.2    Global Chronic Lower Back Pain Treatment Market Analysis 
        8.2.1    Market Overview
            8.2.1.1    Global Chronic Lower Back Pain Treatment Market Historical Value (2017-2023) 
            8.2.1.2    Global Chronic Lower Back Pain Treatment Market Forecast Value (2024-2032)
    8.3     Global Chronic Lower Back Pain Treatment Market by Pain Type
        8.3.1    Market Overview 
            8.3.1.1    Discogenic Pain
            8.3.1.2    Lumbar Spinal Stenosis
            8.3.1.3    Sacroiliac Pain
            8.3.1.4    Facet- Joint Pain
            8.3.1.5    Radicular Pain
            8.3.1.6    Muscular Pain
            8.3.1.7    Others
    8.4    Global Chronic Lower Back Pain Treatment Market by Diagnosis
        8.4.1    Market Overview
            8.4.1.1     Clinical History
            8.4.1.2     Physical Examination
            8.4.1.3     Imaging Guidelines
            8.4.1.4     Others
    8.5    Global Chronic Lower Back Pain Treatment Market by Treatment Channel
        8.5.1    Market Overview
            8.5.1.1    Public
            8.5.1.2    Private
    8.6    Global Chronic Lower Back Pain Treatment Market by Region
        8.6.1    Market Overview
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Middle East and Africa
            8.6.1.5    Latin America
9    North America  Chronic Lower Back Pain Treatment Market
    9.1    Market Share by Country
    9.2    United States of America
        9.2.1    Historical Trend (2017-2023)
        9.2.2    Forecast Trend (2024-2032)
    9.3    Canada
        9.3.1    Historical Trend (2017-2023)
        9.3.2    Forecast Trend (2024-2032)
10    Europe Chronic Lower Back Pain Treatment Market
    10.1    Market Share by Country
    10.2    United Kingdom
        10.2.1    Historical Trend (2017-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    Germany
        10.3.1    Historical Trend (2017-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    France
        10.4.1    Historical Trend (2017-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Italy
        10.5.1    Historical Trend (2017-2023)
        10.5.2    Forecast Trend (2024-2032)
    10.6    Others
11    Asia Pacific Chronic Lower Back Pain Treatment Market
    11.1    Market Share by Country
    11.2    China
        11.2.1    Historical Trend (2017-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    Japan
        11.3.1    Historical Trend (2017-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    India
        11.4.1    Historical Trend (2017-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    ASEAN
        11.5.1    Historical Trend (2017-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Australia
        11.6.1    Historical Trend (2017-2023)
        11.6.2    Forecast Trend (2024-2032)
    11.7    Others
12    Latin America Chronic Lower Back Pain Treatment Market
    12.1    Market Share by Country
    12.2    Brazil
        12.2.1    Historical Trend (2017-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Argentina
        12.3.1    Historical Trend (2017-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Mexico
        12.4.1    Historical Trend (2017-2023)
        12.4.2    Forecast Trend (2024-2032)
    12.5    Others
13    Middle East and Africa Chronic Lower Back Pain Treatment Market
    13.1    Market Share by Country
    13.2    Saudi Arabia
        13.2.1    Historical Trend (2017-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    United Arab Emirates
        13.3.1    Historical Trend (2017-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    Nigeria
        13.4.1    Historical Trend (2017-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    South Africa
        13.5.1    Historical Trend (2017-2023)
        13.5.2    Forecast Trend (2024-2032)
    13.6    Others
14    Global Chronic Lower Back Pain Treatment Market Dynamics
    14.1    Market Drivers and Constraints
    14.2    SWOT Analysis
    14.3    Porter’s Five Forces Model 
    14.4    Key Demand Indicators
    14.5    Key Price Indicators
    14.6    Industry Events, Initiatives, and Trends
    14.7    Value Chain Analysis
15    Supplier Landscape
    15.1    Johnson & Johnson
        15.1.1    Company Overview
        15.1.2    Product Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisitions
        15.1.5    Certifications
    15.2    Pfizer Inc.
        15.2.1    Company Overview
        15.2.2      Product Portfolio
        15.2.3     Demographic Reach and Achievements
        15.2.4     Mergers and Acquisitions
        15.2.5     Certifications
    15.3    Sanofi S.A.
        15.3.1    Company Overview
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    Merck & Co., Inc.
        15.4.1    Company Overview
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Medtronic plc
        15.5.1    Company Overview
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    Endo International plc
        15.6.1    Company Overview
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications
    15.7    Boston Scientific Corporation
        15.7.1    Company Overview
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
    15.8    Koninklijke Philips N.V.
        15.8.1    Company Overview
        15.8.2    Product Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisitions
        15.8.5    Certifications
    15.9    Karl Storz SE & Co. KG
        15.9.1    Company Overview
        15.9.2    Product Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisitions
        15.9.5    Certifications
    15.10     Stryker Corporation
        15.10.1    Company Overview
        15.10.2    Product Portfolio
        15.10.3    Demographic Reach and Achievements
        15.10.4    Mergers and Acquisitions
        15.10.5    Certifications
16    Global Chronic Lower Back Pain Treatment Market- Drug Distribution Model (Additional Insight)
    16.1    Overview 
    16.2    Potential Distributors 
    16.3    Key Parameters for Distribution Partner Assessment
17    Payment Methods (Additional Insight)
    17.1    Government Funded
    17.2    Private Insurance
    17.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

Based on the pain type, the market is segmented into discogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, and muscular pain, among others.

The different regions in this market are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is anticipated to hold a significant share in the market during the forecast period.

There is no effective treatment for complete eradication, but different therapeutic strategies help alleviate symptoms. Anti-inflammatory medications, acupuncture, physical therapy programs and surgical interventions help alleviate and manage chronic lower back pain.

There are two treatment channels in the market: public and private.

Increasing prevalence of neurological disorders, rising adoption of anti-inflammatory drugs, technological advancements, increased research and developmental activities, and better awareness are the driving factors in the market.

The key companies involved in the market are Johnson & Johnson, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Medtronic plc, Endo International plc, Boston Scientific Corporation, Koninklijke Philips N.V., Karl Storz SE & Co. KG, Stryker Corporation, among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER